NetworkNewsBreaks

FridayAug 29, 2025 12:47 pm

NetworkNewsBreaks – Professional Diversity Network, Inc. (NASDAQ: IPDN) Signs MOU With OOKC Group to Develop Web3.0 Banking Platform, Launches Updated TalentAlly Site

Professional Diversity Network (NASDAQ: IPDN), a global operator of online networks that connect diverse professionals with employment opportunities, announced it has signed a non-binding MOU with Dubai-based OOKC Group to co-develop the world’s first compliance-driven Web3.0 digital investment banking platform, targeting real-world asset tokenization, decentralized capital structures and cross-border regulatory innovation. In parallel, the Company launched a redesigned TalentAlly website, featuring upgraded navigation, job search tools, and career resources to better serve underrepresented professionals and inclusive employers. TalentAlly has reported a 44.3% rise in monthly site visitors and 79.8% growth in page views since January 2025, reflecting strong momentum as…

Continue Reading

FridayAug 29, 2025 10:06 am

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Featured in NetworkNewsAudio Release on Colombia Joint Venture

ESGold (CSE: ESAU) (OTCQB: ESAUF) is featured in a new NetworkNewsAudio release titled “Colombia’s Hidden Gold: How Modern Tech Can Unlock Millions from Legacy Mine Waste.” The segment highlights ESGold’s binding memorandum of understanding with Planta Magdalena S.A.S. for a fully permitted gold and silver project in Colombia’s Department of Bolívar. Under the agreement, ESGold will invest C$1.5 million for a 50% joint venture interest, with an option to acquire the remaining 50% within 12 months at fair market value. With production permits already in place, the partnership provides ESGold a rare near-term opportunity to establish a second operation alongside…

Continue Reading

FridayAug 29, 2025 9:49 am

NetworkNewsBreaks – Propanc Biopharma, Inc. (NASDAQ: PPCB) Closes $4 Million Public Offering 

Propanc Biopharma (NASDAQ: PPCB) announced the closing of its underwritten public offering of 1,000,000 shares of common stock at $4.00 per share, generating $4 million in gross proceeds before deducting underwriting discounts and expenses. The Company also granted the underwriter a 45-day option to purchase up to 150,000 additional shares. The shares commenced trading on the Nasdaq Capital Market on Aug. 15, 2025, with the offering closing on Aug. 18, 2025. D. Boral Capital LLC and Craft Capital Management LLC acted as book running managers for the offering. To view the full press release, visit https://nnw.fm/nMTNC About Propanc Biopharma, Inc.…

Continue Reading

FridayAug 29, 2025 9:30 am

NetworkNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Integrates Chainlink Data Services Into Tokenized Money Market Fund

Solowin (NASDAQ: SWIN), a financial services firm providing solutions across traditional and digital assets, announced the integration of Chainlink’s Proof of Reserve and NAVLink into its flagship tokenized money market fund, the Real Yield Token (RYT). Now live on Arbitrum and Polygon, the integration enables real-time, on-chain verification of collateralization and alignment with net asset value, enhancing transparency and institutional appeal as Solowin advances its compliance-first digital asset ecosystem. To view the full press release, visit https://nnw.fm/0PDlC About SOLOWIN HOLDINGS SOLOWIN HOLDINGS (NASDAQ: SWIN) is a leading financial services firm providing comprehensive solutions across traditional and digital assets. Founded in 2016, it…

Continue Reading

FridayAug 29, 2025 9:20 am

NetworkNewsBreaks – Sharps Technology, Inc. (NASDAQ: STSS, STSSW) Closes $400 Million Private Placement, Launches Solana Treasury Strategy

Sharps Technology (NASDAQ: STSS, STSSW) announced the closing of a $400 million private placement of common stock and stapled warrants priced at $6.50 per unit, with total proceeds potentially reaching $1 billion upon full warrant exercise. The Company will use the funds primarily to acquire SOL, the native token of the Solana blockchain, under a new digital asset treasury strategy, supported by a non-binding LOI with the Solana Foundation for a potential $50 million discounted purchase. Backed by a syndicate of global financial institutions and digital asset investors, Sharps intends to provide regular transparency updates on SOL holdings while continuing…

Continue Reading

FridayAug 29, 2025 9:00 am

NetworkNewsBreaks – IBN Relaunches MissionIR, MissionPR and MissionSMR Brands

IBN (InvestorBrandNetwork), a multifaceted communications organization connecting public companies to the investment community, today announced the full redesign and relaunch of its three flagship Mission brands — MissionIR, MissionPR, and MissionSMR. As part of IBN’s Dynamic Brand Portfolio of more than 70 investor-focused outlets, the refreshed platforms enhance targeted exposure for retail and institutional investors. MissionIR delivers investor relations support with content creation, social amplification, and event collaboration; MissionPR provides integrated communications spanning branding, media relations, and marketing; and MissionSMR develops data-driven social media strategies to elevate digital engagement. The relaunch reflects IBN’s commitment to evolving client needs while driving…

Continue Reading

FridayAug 29, 2025 9:00 am

NetworkNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Sees Growth From Veloce Investment and Quadrant Acquisition

SEGG Media (NASDAQ: SEGG, LTRYW), a technology company owning Sports.com, Concerts.com, and Lottery.com, reported continued growth across its portfolio following its investment in Veloce Media Group and Veloce’s subsequent acquisition of creator-led brand Quadrant, co-founded by Formula 1 driver Lando Norris. Quadrant recently secured partnerships with Electronic Arts, T-Mobile, Lego, NordVPN, Revolut and Swarovski, bolstering its role as a premier platform in sport, gaming and digital media. Veloce, which operates the world’s largest racing and gaming media network with over 750 million monthly digital views, reported £12.8 million ($17.5 million) in revenue for the year ending June 2024, a 153%…

Continue Reading

ThursdayAug 28, 2025 3:29 pm

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Eyes Golden Opportunity in MiningNewsWire Podcast

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) was featured in a recent episode of the MiningNewsWire podcast, where its CEO Paul Ténière and Chairman Kal Malhi discussed the company’s short-term production strategy and its long-term positioning. “We’re an interesting company in the fact that we have an advanced gold project in Québec’s Abitibi Gold Belt and a nearby permitted mill. That puts us in a strong position as a near-term gold producer,” Ténière said, adding that today’s prices create favorable conditions for restarting operations and accelerating project timelines. “We have a mining lease at Swanson, which allows us to get into…

Continue Reading

ThursdayAug 28, 2025 3:02 pm

NetworkNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Advances Predictive Power in Cancer Drug Development

Lantern Pharma (NASDAQ: LTRN) recently unveiled a new artificial intelligence module designed to predict the effectiveness of cancer treatment combinations involving DNA-damaging agents (“DDAs”) and DNA damage response inhibitors (“DDRis”). “The technology is integrated into the company’s RADR(R) platform, which supports AI-guided drug development,” reads a recent article. “By embedding this technology into RADR(R), Lantern Pharma continues to position itself as a developer of data-driven approaches to oncology drug development. The module not only improves the chances of clinical success but also aligns with growing industry efforts to personalize cancer treatments based on molecular and genetic profiles.” To view the…

Continue Reading

ThursdayAug 28, 2025 2:37 pm

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Showcases Pipeline and CEO’s Intellectual Property Legacy

Oncotelic Therapeutics (OTCQB: OTLC), a clinical stage biopharmaceutical company developing transformative oncology and immunotherapy treatments, today highlighted its oncology pipeline and the extensive intellectual property contributions of Chairman and CEO Dr. Vuong Trieu, who holds more than 500 filed and 75 issued patents and co-developed blockbuster therapeutics Abraxane(R) and Cynviloq(TM). The Company’s portfolio includes OT-101 in Phase 3 for pancreatic cancer, OXi4503 advancing toward Phase 3 in AML/MDS, CA4P/Fosbretabulin in late-stage repositioning, AL-101 in Phase 2 for Parkinson’s and sexual dysfunctions, AL-102 in discovery for Alzheimer’s, and multiple pediatric rare disease programs with potential to generate Priority Review Vouchers, reinforcing…

Continue Reading